On July 24, Oklo Inc. declined 5.7% in regular trading, trading at approximately $41.72 per share, with turnover of $56.61 million. The stock retreated despite the company announcing that its Groves Isotope Test Reactor (GITR) has received startup authorization from the US Department of Energy, clearing the path for fuel loading, startup testing, and commercial operation.

The decline reflects classic profit-taking behavior. From July 21 to 22, Oklo had already surged over 13% as markets priced in the DOE safety analysis document approval and broader nuclear sector momentum driven by fuel price increases, capital expansion, and demand growth. With the formal authorization now confirmed, investors moved to lock in gains. The broader Electric Utilities sector remained stable during the session, with Oklo's decline notably diverging from peers.

CEO Jacob DeWitte stated that the privately funded project, built on private land, demonstrates that the advanced nuclear industry can progress far faster than previously expected. The GITR milestone positions Oklo to proceed toward first criticality, advancing its broader Aurora powerhouse commercialization strategy targeting liquid metal fast reactor technology.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)